Whetstone Capital Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.01M Hold
1,515,000
0.79% 24
2026
Q1
$1.92M Buy
+1,515,000
New +$2.85M 0.67% 24

Other funds holding HCAT

Whetstone Capital Advisors's HCAT Position: Q2 2026 in Review

Whetstone Capital Advisors reduced its Health Catalyst (HCAT) stake by 96% in Q2 2026, selling an estimated $5.92M and leaving 167,097 shares worth $333K. The position accounts for 0.09% of the portfolio, ranked #42.

Whetstone Capital Advisors first reported a position in HCAT in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.1M in Q2 2025. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Whetstone Capital Advisors held 167,097 shares of Health Catalyst worth $333K as of Q2 2026.
  • Whetstone Capital Advisors sold 4,101,044 Health Catalyst shares in Q2 2026, an estimated $5.92M.
  • Health Catalyst made up 0.09% of Whetstone Capital Advisors's portfolio in Q2 2026, its #42 holding.
  • Whetstone Capital Advisors first reported a position in Health Catalyst in Q1 2025 and has held it in 6 quarters since.
  • Whetstone Capital Advisors's Health Catalyst position peaked at $14.1M in Q2 2025.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Whetstone Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.